US 10829763
TMPRSS6 iRNA compositions and methods of use thereof
granted A61KA61K31/713A61K45/06
Quick answer
US patent 10829763 (TMPRSS6 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/713, A61K45/06, A61P, A61P7/06